Cutaneous pseudolymphoma secondary to gabapentin

BMJ Case Rep. 2018 Oct 21:2018:bcr2018227245. doi: 10.1136/bcr-2018-227245.

Authors

Andrew J Newman¹, Dustin Mullens¹, Christopher Pulford², Travis Lam³

Affiliations

¹ Dermatology Residency, Affiliated Dermatology, Scottsdale, Arizona, USA.
² Microbiology and Immunology, Midwestern University, Glendale, Arizona, USA.
³ Affiliated Dermatology, Scottsdale, Arizona, USA.

No abstract available

Keywords: dermatology; neurology (drugs and medicines); pathology; unwanted effects / adverse reactions.

Publication types

Case Reports

MeSH terms

Analgesics / adverse effects*
Biopsy
Diagnosis, Differential
Female
Gabapentin / adverse effects*
Humans
Middle Aged
Pseudolymphoma / chemically induced*
Pseudolymphoma / diagnosis
Pseudolymphoma / pathology
Skin Diseases / chemically induced*
Skin Diseases / diagnosis
Skin Diseases / pathology

Substances

Analgesics
Gabapentin